Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone Replacement in Metabolic Syndrome
NCT01123278Phase 4Completed
- Sponsor
- Sapienza University of Rome
- Start
- Jan 2004
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Testosterone TEPI patch in Hypogonadism (2 arms), sponsored by Sapienza University of Rome. Primary endpoint: Fat-Free Mass at 3 months. Started Jan 2004; status: completed.
02
Drugs
Testosterone TEPI patch
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT01123278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01123278.